Close X
Attorney Spotlight

In addition to Mark Manner's busy corporate legal practice, he has established himself as a respected and avid astronomer. Read more>


Close X


Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Blueprint for an IPO

Companies go public to raise capital to fuel growth, pay down debt and provide liquidity to shareholders. Although all issuers and offerings are different, the basic process of going public remains relatively constant. Blueprint for an IPO identifies the key players, details the process and identifies the obligations companies will face after going public.

Read now

Attorney Spotlight: Claire Miley

November 7, 2016

Claire Miley Spotlight1. Tell us about your practice. 

For 20 years, I've been helping clients navigate the complex (often downright byzantine) world of Medicare reimbursement and fraud and abuse rules. Healthcare is a constantly shifting landscape, so I never take anything for granted. I have a glass "whiteboard" in my office on which I am constantly drawing diagrams of proposed transactions (usually with multiple colors of dry-erase markers). I want to make sure that I'm not missing a single facet of a deal that could implicate reimbursement, certification or fraud and abuse regulations. 

2. What is an interesting trend happening right now related to your field of practice? 

Even with the usual fluctuations in the healthcare landscape, it would be hard to top the seismic shift represented by the passage of MACRA, the Medicare Access and CHIP Reauthorization Act of 2015. MACRA exponentially accelerates the move to value-based purchasing by government healthcare programs. Just last month, CMS issued final regulations to implement one of the cornerstones of MACRA, the elimination of the Sustainable Growth Rate (SGR) and the old fee-for-service methodology for reimbursing physicians. The old methodology will be replaced with merit-based and alternative payment systems. Healthcare lawyers are living in exciting times. 

3. Why did you choose to pursue a career in the legal field? 

For the intellectual challenge. Practicing as a healthcare regulatory lawyer has certainly never let me down in this respect!

Related Professionals

Related Services


Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.